ScholarLens Back to search
2011•Journal of Medical ForumRequires access

Intravitreal triamcinolone acetonide for treatment of macular edema associate with branch retinal vein occlusion

Yuandong Li

Open publisher page 0 citations

Abstract

Objective To evaluate the efficacy of intravitreal triamcinolon acetonide(ITVA)in the treatment of macular edema associated with branch retinal vein occlusion(BRVO).Methods Twenty-one eyes of 23patients with severe macular edema due to BRVO underwent ITVA with 4mg/0.1ml.Intraocular pressure(IOP),inflammatory extent,manifestation of lens and funds were observed before treatment and one day,three days,one week,one month,three month after treatment.Results In all 23 eyes,20 eyes(86.9%)had improved visual,3 eyes(13.1%)remained the same.The LogMAR vison acusul acuity was(0.75±0.48) before treatment,while 1week,1month,3months after IVTA,the average visual acuity was(0.57±0.43),(0.38±0.32)and(0.29±0.29) respectively.Conclusions ITVA is effective for macular edema secondary to BRVO in a short time.

About this research paper

What this paper is about

Objective To evaluate the efficacy of intravitreal triamcinolon acetonide(ITVA)in the treatment of macular edema associated with branch retinal vein occlusion(BRVO).Methods Twenty-one eyes of 23patients with severe macular edema due to BRVO underwent ITVA with 4mg/0.1ml.Intraocular pressure(IOP),inflammatory extent,manifestation of lens and funds were observed before treatment and one day,three days,one week,one month,three month after treatment.Results In all 23 eyes,20 eyes(86.9%)had improved visual,3 eyes(13.1%)remained the same.The LogMAR vison acusul acuity was(0.75±0.48) before treatment,while 1week,1month,3months after IVTA,the average visual acuity was(0.57±0.43),(0.38±0.32)and(0.29±0.29) respectively.Conclusions ITVA is effective for macular edema secondary to BRVO in a short time.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the efficacy of intravitreal triamcinolon acetonide(ITVA)in the treatment of macular edema associated with branch retinal vein occlusion(BRVO).Methods Twenty-one eyes of 23patients with severe macular edema due to BRVO underwent ITVA with 4mg/0.1ml.Intraocular pressure(IOP),inflammatory extent,manifestation of lens and funds were observed before treatment and one day,three days,one week,one month,three month after treatment.Results In all 23 eyes,20 eyes(86.9%)had improved visual,3 eyes(13.1%)remained the same.The LogMAR vison acusul acuity was(0.75±0.48) before treatment,while 1week,1month,3months after IVTA,the average visual acuity was(0.57±0.43),(0.38±0.32)and(0.29±0.29) respectively.Conclusions ITVA is effective for macular edema secondary to BRVO in a short time.

Key concepts: Medicine, Branch retinal vein occlusion, Macular edema, Ophthalmology, Visual acuity, Intraocular pressure, Triamcinolone acetonide, Acetonide

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Intravitreal triamcinolone acetonide for treatment of macular edema associate with branch retinal vein occlusion — Research Paper | ScholarLens